Mark Hillman - Hillman Capital Management, Inc.
Holding/activity history for Bristol-Myers Squibb (BMY)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 53,102 | 2.24 | Reduce 1.60% | 0.03 | $60.65 | $3,220,636 | SEC |
| 2025 Q4 | 53,966 | 1.83 | Reduce 22.28% | 0.41 | $53.94 | $2,910,926 | SEC |
| 2025 Q3 | 69,440 | 1.82 | Reduce 3.31% | 0.06 | $45.10 | $3,131,744 | SEC |
| 2025 Q2 | 71,815 | 1.81 | Add 10.45% | 0.17 | $46.29 | $3,324,316 | SEC |
| 2025 Q1 | 65,019 | 1.95 | Reduce 43.30% | 1.04 | $60.99 | $3,965,509 | SEC |
| 2024 Q4 | 114,671 | 2.41 | Reduce 28.53% | 0.81 | $56.56 | $6,485,792 | SEC |
| 2024 Q3 | 160,445 | 2.85 | Reduce 0.05% | <0.01 | $51.74 | $8,301,424 | SEC |
| 2024 Q2 | 160,529 | 2.35 | Buy | 2.35 | $41.53 | $6,666,769 | SEC |
| 2022 Q2 | 0 | 0.00 | Sell 100.00% | 3.15 | SEC | ||
| 2022 Q1 | 135,731 | 3.15 | Add 1.34% | 0.04 | $73.03 | $9,912,000 | SEC |
| 2021 Q4 | 133,937 | 2.87 | Reduce 3.15% | 0.09 | $62.35 | $8,351,000 | SEC |
| 2021 Q3 | 138,288 | 2.87 | Add 17.14% | 0.42 | $59.17 | $8,183,000 | SEC |
| 2021 Q2 | 118,057 | 3.00 | Add 0.81% | 0.02 | $66.82 | $7,889,000 | SEC |
| 2021 Q1 | 117,107 | 3.24 | Add 39.43% | 0.92 | $63.13 | $7,393,000 | SEC |
| 2020 Q4 | 83,990 | 2.81 | Add 0.38% | 0.01 | $62.03 | $5,210,000 | SEC |
| 2020 Q3 | 83,674 | 3.55 | Reduce 0.42% | 0.02 | $60.29 | $5,045,000 | SEC |
| 2020 Q2 | 84,026 | 3.60 | Reduce 1.06% | 0.05 | $58.80 | $4,941,000 | SEC |
| 2020 Q1 | 84,930 | 4.53 | Reduce 1.97% | 0.08 | $55.74 | $4,734,000 | SEC |
| 2019 Q4 | 86,641 | 3.94 | Buy | 3.94 | $64.18 | $5,561,000 | SEC |